Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myositis

NCT06450886 is registered in ClinicalTrials.gov with Abcuro, Inc. as lead sponsor.

NCT NCT06450886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06450886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myositis
Lead sponsor
Abcuro, Inc.
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
October 21, 2024
Completion date
April 30, 2029
Enrollment
270 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

inclusion body myositis (ibm)